Common variations in BARD1 influence susceptibility to high-risk neuroblastoma - Wikidata - thesis-toulmin - TriplyDB

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

http://www.wikidata.org/entity/Q24645352

about

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer Genetic and nongenetic risk factors for childhood cancer CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients.The zebrafish as a model for studying neuroblastoma Molecular pathogenesis of peripheral neuroblastic tumors Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma Identification of functional SNPs in BARD1 gene and in silico analysis of damaging SNPs: based on data procured from dbSNP database Overview and recent advances in the treatment of neuroblastoma.Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.Optimal False Discovery Rate Control for Dependent Data Nonsyndromic cleft lip with or without cleft palate and cancer: Evaluation of a possible common genetic background through the analysis of GWAS data HSD17B12 gene rs11037575 C>T polymorphism confers neuroblastoma susceptibility in a Southern Chinese population Research progress of neuroblastoma related gene variations.Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature).BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility.Genome-wide association studies in cancer--current and future directions Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.A compendium of genome-wide associations for cancer: critical synopsis and reappraisal.Pediatric oncology.Integrative genomics identifies LMO1 as a neuroblastoma oncogene.Genome-wide association studies of cancer.Genetic variability in the regulation of gene expression in ten regions of the human brain.Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha.Association of cancer susceptibility variants with risk of multiple primary cancers: The population architecture using genomics and epidemiology study.Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion.RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma.Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study.Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma.Association of three common BARD1 variants with cancer susceptibility: a system review and meta-analysis.Neuroblastoma: developmental biology, cancer genomics and immunotherapy.Candidate Gene Association Analysis of Neuroblastoma in Chinese Children Strengthens the Role of LMO1 Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).The role of intracellular calcium for the development and treatment of neuroblastoma.Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications.

P2860

Q24630017-F14FA3AC-34EA-4C99-B1FB-AF2313D11837 Q27021261-3EF75100-C5D2-40AA-BD77-ED501131EDC6 Q27693894-2E523C84-75C7-4C2A-A94B-E8D44D7128D8 Q27853102-8B048334-18E0-42F8-AF92-C4C540AC95C9 Q28070309-F69EEEAA-D523-46CF-83D0-568388553D92 Q28271405-A9E6AA31-B593-42D8-B0CF-AC020A81EDE1 Q28943271-329DACE2-D60E-41E4-803A-3D0F0448D217 Q30000832-B42160FF-4934-4402-BC6D-7A7DC355331F Q30238693-8112CF2C-FB89-4207-8FA7-F56C81BBD802 Q30239861-7755E782-A171-42C1-9904-B16B753E7311 Q30586885-22C15113-E6C7-4290-A69D-54CCCDC17C03 Q31130933-71125279-A151-4F45-A0F9-215D6A8CAF4E Q33553664-F8888247-1493-4B6E-8C0A-2D3DE16C3B84 Q33566987-A4597E7F-7277-4313-B214-D9D1602DEF7B Q33645629-AA11815B-6EBB-42D0-B63F-945896AE2E09 Q33669451-4BF52F9C-5C4F-44D3-849D-5155AD363FEF Q33809764-BED7DF03-38FD-4817-840F-7334D3CFEBCA Q33814805-AAE1A812-E77F-4AF6-9C2B-4BD0BB3070A2 Q33855434-4A667172-C84A-4040-A109-381AEEB7972B Q33915049-01326B70-7D42-4B8F-940E-92911CEB8EC3 Q34038452-AC1EE718-87F0-4123-8EE4-402FE5F9A90F Q34152903-14748B43-C84C-4A82-8A54-2A2B7B2616F8 Q34193988-78ED6C02-D69D-4B03-8450-558313E68273 Q34398489-55BEC6D5-8FC9-4A00-8D37-8A1D21F64B3A Q34420371-FF79ED32-93F5-452F-B56D-CEDB4EB50833 Q34457646-09A6F0B2-510B-447C-8F5C-F435930C68B9 Q34501408-AA4281AB-FFDB-49B1-8F34-4B0208646E4F Q34558670-020D8D04-DD85-45D0-9DD6-1F6F365E5DF5 Q34602599-A6E97F9A-3607-4FC7-8796-C8FC3433172A Q34609220-18EC75BB-3616-41FB-BA71-B609DB4C6D14 Q34637949-10A785D8-B60B-4B81-9C42-D8C1F731B64E Q34662881-B85C4460-4CF2-4A03-B4FE-38C734D4F01F Q34950211-EB0503C7-144D-46C6-AEDC-C0998D0B2BA1 Q35034812-F1F64ECF-DFC2-4624-91A9-BB0C4178A7F2 Q35173448-ED2B355C-592B-4D86-A440-92AF9ABBFAE6 Q35283020-5139BEE1-CE4B-4EB8-960B-DA10619FF7F1 Q35648303-C51C0DC9-BE22-4ADE-AA4D-132033E2FE67 Q35653969-DFB01D48-60CB-4AD6-B08F-B4E7A879AE15 Q35818437-292D3C98-B852-4979-BA52-3A63BA4E6272 Q35818443-75D3E1E2-4D29-429B-A977-B3D459843F30

P2860

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

http://www.wikidata.org/entity/Q24645352

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

@ast

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

@en

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

@nl

type

label

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

@ast

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

@en

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

@nl

prefLabel

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

@ast

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

@en

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

@nl

P1433

Q24645352-81FE710C-E7F2-4427-91AF-B7E43D094F24

P1476

Q24645352-1F51C861-33F2-4E5B-BCB7-802E2CE824C6

P2093

Q24645352-0E94086F-D37E-4353-8981-0A51F9DA72A7

Q24645352-0EB273B3-1928-4E40-A267-6452FD16F5C1

Q24645352-149FC5E9-DB2E-4956-898D-23D71176C4B8

Q24645352-1DE8C0F0-1A7B-4B06-80C8-510AB2EBB516

Q24645352-2D1D1761-89C6-48BA-A4B6-9515F8853C19

Q24645352-312DFCFD-DF10-4755-A621-8AC0DFEF5387

Q24645352-592F05F1-E1E6-487A-9BA8-F8D916F9D582

Q24645352-5A2C64A3-89F4-4386-BD72-89F215635A53

Q24645352-75D18870-E33D-4885-A4B8-4FBE1DABA237

Q24645352-7B472D3A-3C34-4CB9-8823-78C76EB1006F

P2860

Q24645352-00A83AE4-C61F-46DB-A20A-B05C6BA6FE4B

Q24645352-0CF44A29-219B-4B49-BE30-75CB953B1E62

Q24645352-0F536028-33F3-4CC1-8068-4A7E44DCFF76

Q24645352-15CC3BEA-7EC2-46ED-AB27-5E7E7A3B79C3

Q24645352-1FEE6945-54E1-4370-9042-BB630F69DE72

Q24645352-2EDC838B-9A44-4D45-91AB-0E625598ADE4

Q24645352-3050B8B6-6E0C-4AB0-AB40-98611D26F0E1

Q24645352-36AA6E30-C99C-4CA6-8278-B8C2C3EC4FC0

Q24645352-3B2C73FD-B703-44CC-B9A1-13E5C237E113

Q24645352-6B070358-C964-4FDD-A970-54A7CB46121B

P2888

Q24645352-E9D317DF-43CC-4D98-B5B2-E3142CBA2819

P304

Q24645352-618A8DD8-479E-41C9-8F50-FA435C006ABE

P31

Q24645352-5B2D828E-9B46-47EC-8299-0D7CD40B0A23

P3181

Q24645352-B03BBD4A-3284-4136-99A0-756F21C1DE28

P356

Q24645352-0B2D3A57-2F99-4E4E-9C40-CD9CD421C3D3

P407

Q24645352-17FC3E52-577D-46D1-8EB6-96D89E03D261

P433

Q24645352-2A00AE14-A922-421F-B715-45ED0CFD9376

P478

Q24645352-DAED076A-C79C-44A4-9B50-21A38B7AA4EF

P50

Q24645352-0EE86FB0-546A-438B-AA84-ABCF374D7D4F

Q24645352-667AE453-E260-44AA-9318-49826E13EDF6

Q24645352-6D459858-66CC-42C7-9F6F-D1A6685B25BA

Q24645352-89CEA741-B19C-4135-8211-94F4D9B322EF

Q24645352-C871B879-2178-4389-950E-79B402EBC6A7

Q24645352-E7611133-DC07-41BE-96EC-4766F0CBB8C7

P577

Q24645352-0DDD616F-6D10-44D3-A278-F77D6A6D814C

P5875

Q24645352-2938F48B-DBFB-4194-A24E-9A35749A7283

P6179

Q24645352-F433C0EA-E561-431B-BD8F-7B17E1F9BCA2

P698

Q24645352-70D279DA-44D1-48F9-BA0B-52FBBFD973FD

P932

Q24645352-66B46C3C-CE99-4332-B50D-E52632045B03

P3181

P356

P1433

Nature Genetics

P1476

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

@en

P2093

Carmel McConville

http://www.w3.org/2001/XMLSchema#string

Cuiping Hou

http://www.w3.org/2001/XMLSchema#string

Cynthia Winter

http://www.w3.org/2001/XMLSchema#string

Edward F Attiyeh

http://www.w3.org/2001/XMLSchema#string

Eric Rappaport

http://www.w3.org/2001/XMLSchema#string

Hongzhe Li

http://www.w3.org/2001/XMLSchema#string

Jayanti Jagannathan

http://www.w3.org/2001/XMLSchema#string

John M Maris

http://www.w3.org/2001/XMLSchema#string

Jonathan P Bradfield

http://www.w3.org/2001/XMLSchema#string

Joseph T Glessner

http://www.w3.org/2001/XMLSchema#string

P2860

Population structure and eigenanalysis

Identification of a RING protein that can interact in vivo with the BRCA1 gene product

Genome-wide association study identifies novel breast cancer susceptibility loci

Identification of ALK as a major familial neuroblastoma predisposition gene

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma

PLINK: a tool set for whole-genome association and population-based linkage analyses

Haploview: analysis and visualization of LD and haplotype maps

Principal components analysis corrects for stratification in genome-wide association studies

Is there more to BARD1 than BRCA1?

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

P2888

P304

718-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2782130

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NG.374

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

Marcella Devoto

Hakon Hakonarson

Shahab Asgharzadeh

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24398604

http://www.w3.org/2001/XMLSchema#string

P6179

1025450596

http://www.w3.org/2001/XMLSchema#string

P698

19412175

http://www.w3.org/2001/XMLSchema#string

P932

2753610

http://www.w3.org/2001/XMLSchema#string